As the society begin to realize the importance of combating antimicrobial resistance, going
back to silver might be the solution. Silver has been known for its potential antimicrobial
activity since ancient times and, the development of nanoparticles has increased its potential
into becoming an antimicrobial agent that can be applied in broad-spectrum. Antimicrobial
resistance has spread into an irrepressible manner which requires drastic action plan as a number
of pathogenic bacteria began to acquire resistance genes. Methicillin Resistant Staphylococcus
aureus (MRSA) is one of the earliest reported resistant clones which is the center of this study.
This study focused on the dissemination and evolution of MRSA on its resistance towards
antibiotics. Disc Diffusion Test was employed to create the antibiograms of MRSA isolates. All
isolates showed resistance towards amoxicillin, ampicillin, cefazolin, oxacillin and penicillin.
In contrast, all isolates were susceptible towards erythromycin. The findings also discovered
isolates that were vancomycin-resistant (66.7%) and vancomycin-intermediate (33.3%). As the
efficacy of antibiotic treatment is at a question, we also investigated on the antimicrobial activity
of colloidal silver in the hope as an alternative treatment. Shiga Toxin producing Escherichia
coli (STEC) and MRSA (ATCC 33591) was tested using modified Quantitative suspension
test for the evaluation of bactericidal activity for chemical disinfectants and antiseptics based
on BS EN 1276:2009. The outcome of this study indicated that the colloidal silver is working
effectively against STEC and MRSA (ATCC 33591), showing killing percentages well above
99.0% at 4 minutes and 8 minutes of contact. Vancomycin-resistant S. aureus (VRSA) and
Vancomycin-intermediate S. aureus (VISA) were also tested and the results indicated that
VISA had higher killing percentages at 4 minutes (99.83%) and 8 minutes (99.85%) compared
to VRSA at 4 minutes (96.72%) and 8 minutes (98.35%). This opens a solution to the rising
problem of antimicrobial resistance.
Among the neurodegenerative disorders, Parkinson's disease (PD) ranks as the second most common disorder with a higher prevalence in individuals aged over 60 years old. Younger individuals may also be affected with PD which is known as early onset PD (EOPD). Despite similarities between the characteristics of EOPD and late onset PD (LODP), EOPD patients experience much longer disease manifestations and poorer quality of life. Although some individuals are more prone to have EOPD due to certain genetic alterations, the molecular mechanisms that differentiate between EOPD and LOPD remains unclear. Recent findings in PD patients revealed that there were differences in the genetic profiles of PD patients compared to healthy controls, as well as between EOPD and LOPD patients. There were variants identified that correlated with the decline of cognitive and motor symptoms as well as non-motor symptoms in PD. There were also specific microRNAs that correlated with PD progression, and since microRNAs have been shown to be involved in the maintenance of neuronal development, mitochondrial dysfunction and oxidative stress, there is a strong possibility that these microRNAs can be potentially used to differentiate between subsets of PD patients. PD is mainly diagnosed at the late stage, when almost majority of the dopaminergic neurons are lost. Therefore, identification of molecular biomarkers for early detection of PD is important. Given that miRNAs are crucial in controlling the gene expression, these regulatory microRNAs and their target genes could be used as biomarkers for early diagnosis of PD. In this article, we discussed the genes involved and their regulatory miRNAs, regarding their roles in PD progression, based on the findings of significantly altered microRNAs in EOPD studies. We also discussed the potential of these miRNAs as molecular biomarkers for early diagnosis.
Skin aging is a complex natural process characterised by gradual diminishment of structural integrity and physiological imbalance of the skin tissue. Since the oxidative stress is tightly corelated to the skin aging process, the usage of antioxidant may serve as favourable strategies for slowing down the skin aging process. Mangosteen is an important fruit commodity and its extract had been extensively studied and revealing various biological activities. Present study aimed to assess the antioxidant and antiaging activity of mangosteen peel extract (MPE) and its phytochemical compounds. MPE and its compounds were subjected to ferric reducing antioxidant power (FRAP), hydroperoxide (H2O2) scavenging, anti-collagenase, anti-elastase, anti-hyaluronidase and anti-tyrosinase assay. MPE has the highest FRAP 116.31 ± 0.60 μM Fe(II) μg-1 extract, IC50 of MPE on H2O2 scavenging activity was 54.61 μg mL-1. MPE also has the highest anti elastase activity at IC50 7.40 μg mL-1. Alpha-mangostin showed potent anti-collagenase activity (IC50 9.75 μg mL-1). While gamma-mangostin showed potent anti-hyaluronidase (IC50 23.85 μg mL-1) and anti-tyrosinase (IC50 50.35 μg mL-1). MPE and its compounds were evaluated in vitro for antioxidant and antiaging activities. Current findings may provide scientific evidence for possible usage of mangosteen extract and its compounds as antioxidant and antiaging agent.